Metrics to compare | SILV | Peers Peers - average of corresponding metrics from companies closely matching SILV: CENTRALPHL, SILCOPHL, ORIONPHARM, IBP, TECHNODRUG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipSILVPeersSector |
|---|---|---|---|---|
P/E Ratio | −10.7x | 11.5x | −0.2x | |
PEG Ratio | 0.48 | 0.19 | 0.00 | |
Price/Book | 0.9x | 1.2x | 2.6x | |
Price / LTM Sales | 5.4x | 2.2x | 2.6x | |
Upside (Analyst Target) | - | 22.7% | 76.9% | |
Fair Value Upside | Unlock | 1.6% | 14.9% | Unlock |
Silva Pharmaceuticals Limited engages in manufacturing and marketing of pharmaceuticals finished products in Bangladesh and internationally. The company offers drugs for various categories, including antibiotics, analgesics, anti-diabetics, narcotics, anti-pyretics, anti-inflammatory, anti ulcerants, antiemetic, gastroprokinetic, antihistamine, anti-spasmodic expectorants, and vitamins and mineral. It also provides pharmaceutical products in therapeutic areas, such as central nervous system, gastro- intestinal system, nutrition, anti-infectives, disinfectant, musculoskeletal and joint disease, respiratory system, cardiovascular system, endocrine system, and natural sweeteners. The company was incorporated in 2001 and is headquartered in Dhaka, Bangladesh.